DCM
GYRE icon

DAFNA Capital Management’s Gyre Therapeutics GYRE Stock Holding History

DAFNA Capital Management’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-630
Closed -$86K – 68
2016
Q3 		$86K Hold
630
– – 0.06% 70
2016
Q2 		$108K Hold
630
– – 0.09% 85
2016
Q1 		$119K Hold
630
– – 0.1% 82
2015
Q4 		$222K Hold
630
– – 0.2% 64
2015
Q3 		$330K Buy
630
+41
+7% +$62.5K 0.33% 64
2015
Q2 		$1.29M Sell
589
-2
-0.3% -$4.01K 1.09% 31
2015
Q1 		$1.38M Hold
591
– – 1.06% 28
2014
Q4 		$1.22M Buy
591
+421
+248% +$811K 0.97% 29
2014
Q3 		$339K Buy
+170
New +$420K 0.34% 45

Other funds holding GYRE

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
CCM
Colorado Capital Management Boulder, Colorado $293M AUM 22.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return